Skip to main content
. 2008 Jan 11;61(1):40–48. doi: 10.1016/j.diagmicrobio.2007.12.002

Fig. 3.

Fig. 3

Line immunoassay evaluation probing sera sampled from convalescent SARS patients. A representative selection of immunoassay strips out of 49 samples is shown. Without exception, all samples clearly display strong signals to SARS nucleocapsid as expected. In addition, various combinations of reactions with other HCoV strains are shown. Anti-N, serum from rabbits immunized with recombinant SARS-CoV nucleocapsid was used in the assay. The immunoassay demonstrates a distinct and specific reaction with SARS N.